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Summary Backeround and obiective A low activated protein C (APC) response increases the risk of venous thrombosis, 
and possibly arterial disease. Apart from the factor V Leiden mutation, other factors may determine the level of APC 
response, In most studies on the association with arterial disease, cardiovascular isk factors were not appropriately 
controlled for as possible confounders. We studied the association of APC response to cardiovascular isk factors in a 
sample of the general population. 
Methods The Rotterdam Study is a cohort study among 7983 subjects aged 55 years or over, living in the Ommoord suburb 
in Rotterdam, The Netherlands. APC response was measured in 928 subjects as part of two case-control studies (subjects 
with and without symptomatic cardiovascular disease (CVD) and with and without dementia). APC response was 
determined in double centrifuged platelet poor plasma. Those on anticoagulants were excluded. Linear regression analyses 
were done in age strata (55-64, 65-74, 75-84, >_85), with adjustment for age, sex, CVD, and dementia. 
Results APC response was lower in women than in men (difference 0.56 (p<0.01)). In men, APC response decreased with 
age (0.15 per decade (p=0.02)). In women, a non-significant rise was seen (0.05 per decade (p=0.27)). Associations with 
cardiovascular isk factors differed by age, not gender. In those aged 55-64 years inverse associations were found with 
total cholesterol (0.14 decrease per 1 mmol/I increase, p=0.03) and diastolic pressure (0.12 decrease per 10 mmHg 
increase, p=0.06). In those aged >85 years a positive association was seen with smoking (0.76 increase, p=0.01). No 
associations were found with systolic pressure and body mass index. 
Conclusion These findings suggest that in the elderly age, gender, serum lipids, diastolic pressure and smoking may 
influence APC response, the extent of which may differ by age. These factors should be allowed for in studies on the 
association between APC response and arterial disease. 
INTRODUCTION 
A low response to activated protein C (APC) points 
towards a decreased ability of activated protein C to exert 
its natural anticoagulant properties. Consequently one may 
envision that a low APC response may lead to increased 
risk of venous thrombosis and possibly arterial disease. A 
low APC response has indeed been identified as a risk 
factor for venous thrombosis. 1'2 Its relation with arterial 
disease remains, however, to be established. 3"4 A low APC 
response has frequently been reported to be due to a single 
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base mutation of the factor V gene. 57 Consequently, the 
APC response test has been widely used as a screening test 
for the factor V Leiden mutation, in which an arbitrary 
cutoff point among control subjects was chosen to identify 
subjects 'resistant' to activated protein C. APC response is, 
however, a continuously distributed characteristic and, 
apart from the factor V Leiden mutation, other factors may 
determine the level of an APC response. 8 In most studies on 
the association with arterial disease, APC response was 
dichotomized and established cardiovascular risk factors 
were not appropriately allowed for as possible confounders. 
Most studies were performed among young and middle- 
aged subjects. 
We evaluated the association between APC response and 
established cardiovascular disease risk factors in a sample 
of the general population, aged 55 years or over. 
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METHODS 
Population 
The Rotterdam Study is a single centre prospective follow- 
up study of disease and disability in the elderly, described 
in detail elsewhere. 9 Eligible participants included all 
residents 55 years and older living in the Rotterdam suburb 
of Ommoord, in the Netherlands. Baseline measurements 
were made from March 1990 to July 1993. Of the 10,275 
eligible participants, 7,983 participated (78%). The study 
has been approved by the Medical Ethics Committee of the 
Erasmus University and written informed consent was 
obtained from all participants. 
The analyses presented here are based on 928 subjects that 
were part of two case-control studies. One case control 
study consisted of case-subjects, who were selected on the 
presence of either a myocardial infarction on the 
electrocardiogram (n=92), history of angina pectoris 
(n=123), a history of stroke (n=48), a history of transient 
ischemic attack (n=50) or presence of peripheral arterial 
disease (n=ll2), and control subjects (n=218), who were 
free from symptomatic ardiovascular disease, had a 
normal ECG and an ankle-to-brachial blood pressure index 
above 0.9. 4 The other case control study consisted of 
demented subjects (n=99) and non-demented control 
subjects (n=209). Some subjects were part of both case- 
control studies (n=32). Control subjects for both case- 
control studies were randomly drawn from the Rotterdam 
study participants, frequency matched on age. Subjects on 
anticoagulant drugs were excluded. 
Cardiovascular risk factors 
A subject's moking status, based on data obtained uring a 
home interview, was classified as current, former, and 
never smoker. Data on other risk factors were collected at 
the Rotterdam Study research centre. Height and weight 
were measured and body mass index calculated (kg/m2). 
Sitting blood pressure was measured on the right upper arm 
with a random-zero sphygmomanometer using a 32 by 17 
cm cuff. Diastolic blood pressure was recorded at the fifth 
phase. The average of two measurements obtained at one 
occasion, separated by a count of the pulse rate, was used in 
the analysis. 
Blood sampling procedures and storage have been 
described elsewhere. ]° In short, non-fasting blood was 
collected in tubes containing 0.129 M sodium citrate. All 
tubes were stored on ice before and after blood sampling. 
Platelet poor plasma was obtained by a two stage 
centrifugation: firstly at 1600 g, at 4°C for 10 minutes and 
after carefully transferring the plasma midlayer a second 
centrifugation was performed at 10000 g, at 4°C for l0 
minutes. Plasma was immediately frozen in liquid nitrogen 
and stored at -80°C. Plasma from 30 apparently healthy 
volunteers was centrifuged for 30 minutes at 2000 g, at 4°C 
and pooled to serve as reference plasma. The response of 
the plasma activated partial thromboplastin time (APTT) to 
APC was determined using the Coatest APC resistance test 
of Chromogenix, MOlndal, Sweden and expressed as the 
ratio of APTT with and without addition of APC. Assays 
were performed on a MLA Electra 1000C. APC response in 
the pooled plasma was 3.27. Fibrinogen was determined 
using a nephelometric method. Factor VIII activity was 
determined using a chromogenic assay. Total cholesterol 
and high density lipoprotein (HDL) cholesterol were 
determined by an automated enzymatic procedure. 
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Fig. 1 APC response by age and gender. 
Data analysis 
A priori, multivariate linear regression analyses were 
performed in strata of age (55-64, 65-74, 75-84, >85) and 
gender (men, women). Results are adjusted for age, gender, 
symptomatic ardiovascular disease and dementia. APC 
resistance was defined as a APC response lower than 2.05, 
calculated as the (mean-2SD) based on the APC 
distribution in 312 subjects free from cardiovascular 
disease and dementia. 
RESULTS 
General characteristics are described in table 1. Figure 1 
shows that APC response was lower in women than in men 
with a mean difference of 0.56 (95% CI 0.40,0.70). In men, 
APC response decreased with age (0.15 per decade, (95% 
CI 0.03,0.27)). For women, a non significant increase with 
age was seen (0.05 per decade (95% CI 0.03,0.13). The 
prevalence of APC resistance was 0.9% (95% CI 0.1-2. l) in 
men and 1.5% (95% CI 0.5-2.5) in women: 
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Table 1 General characteristics of the study population. 
Age (years) 
Characteristic 55-64 65-74 75-84 >_85 All 
Number 196 260 292 180 928 
Age (arrows) 61.0 (2.7) 70.0 (2.7) 79.8 (2.9) 88.8 (3.0) 74.8 (10.0) 
Women (%) 54.6 53.0 66.8 78.8 62.7 
Dementia (%) 0.5 6.1 19.1 26.6 13.0* 
Symptomatic CVD 71.8 58.4 58.9 62.2 62.1 * 
Systolic pressure (mmHg) 135 (21) 144 (24) 148 (24) 149 (28) 145 (25) 
Diastolic pressure (mmHg) 74 (11) 76 (12) 73 (13) 72 (14) 74 (13) 
Total cholesterol (mmol/I) 6.8 (1.1) 6.6 (1.2) 6.4 (1.2) 6.1 (1.4) 6.5 (1.2) 
HDL cholesterol (mmol/I) 1.3 (0.4) 1.3 (0.4) 1.3 (0.4) 1.4 (0.3) 1.3 (0.4) 
Body mass index (kg/m 2) 26.1 (3.6) 26.6 (3.5) 26.5 (4.0) 25.2 (3.7) 26.2 (3.7) 
Current smoking (%) 28.5 19.2 12.2 12.2 17.6 
APC response 4.36 (1.1) 4.13 (1.0) 4.05 (1.0) 4.13 (1.2) 4.15 (1.1) 
Values are proportions or means with standard deviations in parentheses. Results are unadjusted. 
* Selection criterium for case-control study, from which the APC data are derived. 
Table 2 Mean change in APC response (standard error) with one unit increase in a cardiovascular risk factor. 
Age (years) 
Risk factor 55-64 65-74 75-84 >_85 Total group 
Mean SE p Mean SE p Mean SE p Mean SE p Mean SE p 
Systolic pressure (10 mmHg) 0.02 (0.04) 0.65 0.03 (0.03) 0.32 0.01 (0.03) 0.70 0.01 (0.03) 
Diastolic pressure (10 mmHg) -0.12 (0.06) 0.06 0.06 (0.05) 0.23 0.09 (0.05) 0.04 0.04 (0.07) 
Total cholesterol(1 mmol/I) -0.14 (0.07) 0.03 0.03 (0.05) 0.57 -0.02 (0.05) 0.68 -0.01 (0.10) 
HDL cholesterol (1 mmol/I) -0.07 (0.22) 0.75 -0.08 (0.17) 0.62 -0.03 (0.17) 0.85 0.26 (0.26) 
Body mass index (10 kg/m2) -0.11 (0.19) 0.56 0.08 (0.18) 0.64 0.13 (0.15) 0.39 0.01 (0.24) 
Current smoking (yes vs no) 0.19 (0.16) 0.22 0.26 (0.16) 0.09 -0.03 (0.19) 0.87 0.76 (0.30) 
0.97 0.01 (0.02) 0.48 
0.51 0.03 (0.03) 0.29 
0.88-0.05 (0.03) 0.12 
0.32-0.01 (0.10) 0.88 
O.95 O.O4 (0.09) 0.7O 
0.01 0.22 (0.09) 0.02 
Fibrinogen(gr/I)t 0.14 (0.24) 0.56 0.26 (0.19) 0.17 0.26 (0.21) 0.23 -0.61 (0.24) 0.01 0.001 (0.11) 0.99 
Factor VIII activity(IU/ml)t -0.32 (0.19) 0.09 -0.12 (0.13) 0.33 -0.05 (0.13) 0.69 0.07 (0.17) 0.69 0.09 (0.07) 0.24 
APTTf 0.00 (0.03) 0.96 -0.01 (0.03) 0.67 0.04 (0.04) 0.32 0.12 (0.05) 0.02 0.03 (0.02) 0.16 
Values are regression coefficients obtained with multivariate linear regression analysis with adjustment for age, gender, dementia, and 
symptomatic ardiovascular disease. 
1"Data on fibrinogen and APTT available for 245 subjects (51,62,74,58); data on factor Vlll activity for 734 subjects (158,217,224,135). 
Associations between APC response and cardiovascular 
risk factors differed by age, not gender. Overall, only 
smoking was associated with APC response: smokers had 
higher mean levels (table 2). In those aged 55-64 years 
inverse associations were found with total cholesterol (0.14 
(95% CI 0.01,0.27) decrease per 1 mmol/1 increase) and 
diastolic blood pressure (0.12 (95% CI -0.0,0.24) decrease 
per 10 mmHg increase). In subjects aged _>85 years a strong 
positive association was seen with current smoking (0.76 
(95% CI 0.16,1.36) increase). Systolic pressure, HDL 
cholesterol and body mass index were not associated with 
APC response. 
The associations between APC response and fibrinogen, 
factor VIII activity and APTT were different across the age 
strata (table 2). For fibrinogen, direction of the association 
in those aged 85 years or over was opposite to that of their 
younger counterparts. The association with factor VIII 
activity was generally inverse and most strong in those 
below the age of 75 years. The association with APTT was 
strongest in the very old. 
DISCUSSION 
These findings suggest that in the elderly, age, gender, total 
cholesterol, diastolic blood pressure and smoking may 
influence APC response, the extent of which may differ by 
age. 
APC response levels in our study were higher than reported 
by others. As a consequence, the prevalence of 'resistance 
to activated protein C', was lower than those reported 
earlier. The relatively higher APC response levels are most 
likely due differences across studies in methods of 
processing the blood. We evaluated APC response in 
double centrifuged platelet poor plasma. A decreased 
number of platelets in plasma has been associated with an 
increased APC response, n Alternatively, higher APC 
response levels in our cross-sectional study might in part be 
a consequence of survival, i.e., those with lower APC levels 
have either died or suffered from arterial disease, resulting 
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in non-participation in the Rotterdam Study. When 
however, this notion is true, it is appears to be more 
apparent in women than in men (figure 1). 
A low APC response has frequently been reported to be due 
to a single base mutation of  the factor V gene. In some 
subjects, however, a low APC response was present in the 
absence of  factor V Leiden mutation and some subjects 
with factor V Leiden mutation had a normal APC 
response, s Furthermore, APC response is a continuous 
parameter which may yield valuable information 
concerning the protein S / protein C system across all 
levels. An unique feature of the present study is that APC 
response was looked upon as a continuous parameter, rather 
than a dichotomous one. 
The main inference from the present study is that the level 
of  APC response is to some extent determined by 
increasing age, female sex, increased diastolic blood 
pressure, increased total cholesterol and smoking. These 
factors should be allowed for in studies on the association 
between APC response and arterial disease. In particular 
when factors such as age, gender, diastolic blood pressure, 
cholesterol and smoking are differently distributed between 
cases and controls, unadjusted results may be biased 
towards a positive or negative finding. 
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